Physician profile
Mayank Saxena
NPI 1598188302
$3,938.40
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $254 · 2021: $2,995 · 2022: $403 · 2023: $73.64 · 2024: $51.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107 · Honoraria: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.49 |
| Honoraria | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $3,109.97 | 2019-2024 | Invisalign |
| A-Dec, INC. | $378.21 | 2022 | |
| Straumann USA LLC | $178.04 | 2021 | |
| Henry Schein, INC. | $82.91 | 2021 | |
| Implant Direct Sybron International LLC | $71.29 | 2019 | |
| Philips North America LLC | $27.81 | 2019-2021 | |
| Envista Holdings Corporation | $18.78 | 2024 | Spark |
| Benco Dental Supply Co. | $17.44 | 2024 | |
| Nobel Biocare USA | $16.96 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2020 | |
| Dentsply Sirona Orthodontics INC | $12.16 | 2019 | |
| Gc America INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.